ArticleJournal of cancer research and clinical oncology2015

Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study.

Faisal Aziz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.